These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35645793)

  • 1. Cinnamaldehyde Suppressed EGF-Induced EMT Process and Inhibits Ovarian Cancer Progression Through PI3K/AKT Pathway.
    Wang Y; Li Y; Wang L; Chen B; Zhu M; Ma C; Mu C; Tao A; Li S; Luo L; Ma P; Ji S; Lan T
    Front Pharmacol; 2022; 13():779608. PubMed ID: 35645793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer.
    Yang HW; Lan Y; Li A; Wu H; Song ZW; Wan AL; Wang Y; Li SB; Ji S; Wang ZC; Wu XY; Lan T
    Front Pharmacol; 2023; 14():1288883. PubMed ID: 38026996
    [No Abstract]   [Full Text] [Related]  

  • 3. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
    Liao H; Zhang L; Lu S; Li W; Dong W
    Front Genet; 2022; 13():848926. PubMed ID: 35812733
    [No Abstract]   [Full Text] [Related]  

  • 4. OCT4 induces EMT and promotes ovarian cancer progression by regulating the PI3K/AKT/mTOR pathway.
    Xie W; Yu J; Yin Y; Zhang X; Zheng X; Wang X
    Front Oncol; 2022; 12():876257. PubMed ID: 36033461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cucurbitacin B inhibits TGF-β1-induced epithelial-mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways.
    Yuan R; Fan Q; Liang X; Han S; He J; Wang QQ; Gao H; Feng Y; Yang S
    Chin Med; 2022 Feb; 17(1):24. PubMed ID: 35183200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway.
    Xiao W; Liu Y; Dai M; Li Y; Peng R; Yu S; Liu H
    Int J Mol Med; 2020 Aug; 46(2):700-708. PubMed ID: 32626924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CALD1 facilitates epithelial-mesenchymal transition progression in gastric cancer cells by modulating the PI3K-Akt pathway.
    Ma WQ; Miao MC; Ding PA; Tan BB; Liu WB; Guo S; Er LM; Zhang ZD; Zhao Q
    World J Gastrointest Oncol; 2024 Mar; 16(3):1029-1045. PubMed ID: 38577446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irisin/FNDC5 inhibits the epithelial-mesenchymal transition of epithelial ovarian cancer cells via the PI3K/Akt pathway.
    Zhu T; Zhang W; Zhang Y; Lu E; Liu H; Liu X; Yin S; Zhang P
    Arch Gynecol Obstet; 2022 Sep; 306(3):841-850. PubMed ID: 35156135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway.
    Lin M; Xiao Y; Dai Y; Mao Y; Xu L; Zhang Q; Chen Z
    Clin Transl Oncol; 2024 Apr; 26(4):951-965. PubMed ID: 37848695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinnamaldehyde Downregulation of Sept9 Inhibits Glioma Progression through Suppressing Hif-1
    Wang Z; Wang C; Fu J; Liu R; Zhou X
    Dis Markers; 2022; 2022():6530934. PubMed ID: 35096204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway.
    Hu J; Wang M; Yang Y; Xing Y; Li S
    Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):719-731. PubMed ID: 35736813
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardamonin inhibits the progression of oesophageal cancer by inhibiting the PI3K/AKT signalling pathway.
    Wang Z; Liu H; Hu Q; Shi L; Lü M; Deng M; Luo G
    J Cancer; 2021; 12(12):3597-3610. PubMed ID: 33995637
    [No Abstract]   [Full Text] [Related]  

  • 15. Acacetin inhibits invasion, migration and TGF-β1-induced EMT of gastric cancer cells through the PI3K/Akt/Snail pathway.
    Zhang G; Li Z; Dong J; Zhou W; Zhang Z; Que Z; Zhu X; Xu Y; Cao N; Zhao A
    BMC Complement Med Ther; 2022 Jan; 22(1):10. PubMed ID: 35000605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway.
    Wang Y; Li Y; Wang L; Chen B; Zhu M; Ma C; Mu C; Tao A; Li S; Luo L; Ma P; Ji S; Lan T
    Front Pharmacol; 2024; 15():1427330. PubMed ID: 39040470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UNBS5162 inhibits SKOV3 ovarian cancer cell proliferation by regulating the PI3K/AKT signalling pathway.
    Wang Q; Shi W
    Oncol Lett; 2019 Mar; 17(3):2976-2982. PubMed ID: 30854075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinnamaldehyde Attenuates the Progression of Rheumatoid Arthritis through Down-Regulation of PI3K/AKT Signaling Pathway.
    Li X; Wang Y
    Inflammation; 2020 Oct; 43(5):1729-1741. PubMed ID: 32851511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.